Inappropriate Prescriptions in Urgent Care: A Growing Concern
Urgent care centers are facing challenges with overprescription of antibiotics, glucocorticoids, and opioids, highlighting the need for improved prescribing practices to enhance patient safety.
Urgent care centers are increasingly associated with the overprescription of medications such as antibiotics, glucocorticoids, and opioids, raising concerns about patient safety and medication overuse. A recent research study published in the Annals of Internal Medicine examined millions of outpatient visits across the United States from 2018 to 2022, revealing that a significant proportion of urgent care visits led to prescriptions that were often inappropriate.
The study analyzed data from over 270 million Americans, identifying more than 12.9 million Medicare beneficiaries. It found that 12.4% of urgent care visits resulted in antibiotic prescriptions, 9.1% involved glucocorticoid prescriptions, and 1.3% included opioids. Notably, antibiotics were frequently prescribed for cases where their use was not justified, including conditions such as otitis media, urinary tract symptoms, and bronchitis, even when guidelines indicated that antibiotics were not necessary.
Similarly, glucocorticoids were often prescribed inappropriately, especially for upper respiratory infections, sinusitis, and bronchitis. Opioids, while less commonly prescribed, were still frequently dispensed for non-back musculoskeletal pain, abdominal discomfort, and sprains, with many instances deemed inappropriate by clinical standards.
Dr. Shirley Cohen-Mekelburg from the University of Michigan emphasized that the pattern of inappropriate medication prescribing persists in urgent care settings. These practices not only contribute to unnecessary medication exposure but also carry risks of adverse effects and the development of antibiotic resistance.
The researchers advocate for multifaceted programs aimed at reducing unnecessary prescribing in urgent care environments, emphasizing the need for better adherence to clinical guidelines to minimize harm while still addressing patient needs. Addressing this issue is vital for improving healthcare quality and safeguarding public health.
For more information, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
reassuring cardiac safety profile of pharmaceutical cannabidiol formulation
A recent study reveals that a pharmaceutical cannabidiol formulation demonstrates a favorable safety profile, including no significant cardiac safety concerns, in patients with cardiovascular risk factors. Ongoing trials continue to explore its potential benefits.
Household Mold as a Significant Cause of Hypersensitivity Pneumonitis
Indoor mold exposure significantly contributes to hypersensitivity pneumonitis, a serious lung disease. New research highlights the importance of environmental assessments and mold removal for patient health.
Promising Drug Combination for Early Post-Myocardial Infarction Treatment
A pioneering preclinical study reveals that combining empagliflozin with sacubitril/valsartan could enhance early healing and reduce complications after a heart attack, paving the way for new treatment strategies.
Study Highlights Regulatory Challenges for Autonomous AI in Healthcare
Emerging autonomous AI agents in healthcare surpass current medical device regulations, prompting calls for regulatory reform to ensure safety and foster innovation.